Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Schuligoi, R; Sedej, M; Waldhoer, M; Vukoja, A; Sturm, EM; Lippe, IT; Peskar, BA; Heinemann, A.
Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
J Leukoc Biol. 2009; 85(1): 136-145.
Doi: 10.1189/jlb.0608387
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Leading authors Med Uni Graz
- Heinemann Akos
- Schuligoi Rufina
- Co-authors Med Uni Graz
- Böhm Eva
- Lippe Irmgard Theresia
- Peskar Bernhard
- Sedej Miriam
- Vukoja Anela
- Waldhoer Maria
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The major mast cell product PGD2 is released during the allergic response and stimulates the chemotaxis of eosinophils, basophils, and Th2-type T lymphocytes. The chemoattractant receptor homologous molecule of Th2 cells (CRTH2) has been shown to mediate the chemotactic effect of PGD2. PGH2 is the common precursor of all PGs and is produced by several cells that express cyclooxygenases. In this study, we show that PGH2 selectively stimulates human peripheral blood eosinophils and basophils but not neutrophils, and this effect is prevented by the CRTH2 receptor antagonist (+)-3-[[(4-fluorophenyl)sulfonyl] methyl amino]-1,2,3,4-tetrahydro-9H-carbazole-9-acetic acid (Cay10471) but not by the hematopoietic PGD synthase inhibitor 4-benzhydryloxy-1-[3-(1H-tetrazol-5-yl)-propyl]piperidine (HQL79). In chemotaxis assays, eosinophils showed a pronounced migratory response toward PGH2, but eosinophil degranulation was inhibited by PGH2. Moreover, collagen-induced platelet aggregation was inhibited by PGH2 in platelet-rich plasma, which was abrogated in the presence of the D-type prostanoid (DP) receptor antagonist 3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxo-1-(phenylmethyl)-4-imidazolidine-heptanoic acid (BWA868c). Each of these effects of PGH2 was enhanced in the presence of plasma and/or albumin. In eosinophils, PGH2-induced calcium ion (Ca2+) flux was subject to homologous desensitization with PGD2. Human embryo kidney (HEK)293 cells transfected with human CRTH2 or DP likewise responded with Ca2+ flux, and untransfected HEK293 cells showed no response. These data indicate that PGH2 causes activation of the PGD2 receptors CRTH2 and DP via a dual mechanism: by interacting directly with the receptors and/or by giving rise to PGD2 after catalytic conversion by plasma proteins.
- Find related publications in this database (using NLM MeSH Indexing)
- Basophils - drug effects
- Blood Proteins - pharmacology
- Calcium - physiology
- Carbazoles - pharmacology
- Cations, Divalent - pharmacology
- Cell Degranulation - pharmacology
- Cell Line - pharmacology
- Chemotaxis - pharmacology
- Collagen - metabolism
- Eosinophils - drug effects
- Humans - drug effects
- Hydantoins - pharmacology
- Intramolecular Oxidoreductases - antagonists and inhibitors
- Lipocalins - antagonists and inhibitors
- Neutrophils - drug effects
- Piperidines - pharmacology
- Prostaglandin H2 - pharmacology
- Receptors, Immunologic - agonists
- Receptors, Prostaglandin - agonists
- Sulfonamides - pharmacology
- Find related publications in this database (Keywords)
- allergy
- D-type prostanoid
- HEK293
- D-type prostanoid receptor
- platelet aggregation
- degranulation